Biotech entity
pharma is the sole category represented across all 1 tracked stories. GSK is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Smithfield Foods, all published on April 30, 2026.
Last mentioned: Apr 30, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. GSK is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. We currently track 1 Biotech story that mention Smithfield Foods, all published on April 30, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Smithfield Foods. Shared-story counts are live from our verified record — not editorial picks.
Source Publication
Related article published, summarizing key highlights from the earnings call.
GSK Q1 Earnings Call
GSK announced strong Q1 sales growth and reaffirmed full-year guidance during their earnings call.
GSK's strong Q1 performance signals growth in biotech innovation, with sales up and full-year guidance intact, potentially accelerating clinical trials and FDA approvals. This development underscores opportunities in gene therapy and vaccines for biotech firms. Investors in the sector should watch for ripple effects on R&D investments.
Source: finance.yahoo.com · Yahoo! News
Smithfield Foods is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
